|
Volumn 35, Issue 2, 2001, Pages 62-71
|
A pharmacokinetic drug-drug interaction study of venlafaxine and indinavir.
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIDEPRESSANT AGENT;
CYCLOHEXANOL DERIVATIVE;
CYP3A PROTEIN, HUMAN;
CYTOCHROME P450;
INDINAVIR;
PROTEINASE INHIBITOR;
VENLAFAXINE;
ADULT;
ARTICLE;
CLINICAL TRIAL;
DRUG INTERACTION;
FEMALE;
GENETICS;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HUMAN;
MALE;
METABOLISM;
PHENOTYPE;
ADULT;
ANTIDEPRESSIVE AGENTS, SECOND-GENERATION;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
CYCLOHEXANOLS;
CYTOCHROME P-450 ENZYME SYSTEM;
DRUG INTERACTIONS;
FEMALE;
HIV PROTEASE INHIBITORS;
HUMANS;
INDINAVIR;
MALE;
PHENOTYPE;
|
EID: 0035295976
PISSN: 00485764
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (34)
|
References (0)
|